Women's Health and Menopause: Risk Reduction Strategies: v. 11 (Medical Science Symposia) - Image 1

£78.57

Springer Women's Health and Menopause: Risk Reduction Strategies: v. 11 (Medical Science Symposia)

Name: Women's Health and Menopause: Risk Reduction Strategies: v. 11 (Medical Science Symposia)
Brand: Springer
Price: 78.57 GBP
Availability: InStock

Gynaecology & Obstetrics

It has never been this cheap. We have no record of a lower price.

£79 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 54 days · 54 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 54 days • 1 price levels

Days at Price

Price Analysis

Most common price: £79 (54 days, 100.0%)

Price range: £79 - £79

Price levels: 1 different prices over 54 days

Description

Despite its universality in human female ageing, the menopause and its biology are not completely understood. New biologic mechanisms by which sex hormones may be detrimental or confer protection are continually being discovered. We are now starting to understand that the role of the oestrogen receptor is not identical in all tissues. Important nongenomic effects for sex hormones have also been described. Hormone replacement therapy (HRT) has produced effects on health risks: some are reduced, some are increased, and the rest remain uncertain. HRT is being used by an increasing number of women to alleviate climacteric symptoms in the perimenopausal period and to prevent osteoporosis and cardiovascular disease later. Positive effects on Alzheimer's disease and dementia on the one hand, and an increase in venous thrombosis on the other, are currently being reported by several groups. Both the preventive benefits and the risk of breast cancer seem to be linked to long-term and current use. HRT requires further testing through specific clinical trials, currently underway in the United States, before confident recommendations may be made about the full range of benefits and risks.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0792346971
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Gynaecology & Obstetrics
Domain: Amazon UK
Release Date: 01 January 1997
Listed Since: 09 December 2006

Barcode

No barcode data available

Springer Women's Health and Menopause: Risk Reduction Strategies: v. 11 (Medical Science Symposia)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Women’s Health and Menopause: Risk Reduction Strategies ― Improved Quality of Health: 13 (Medical Science Symposia Series, 13)

Biologie und Epidemiologie der Hormonersatztherapie - Biology and Epidemiology of Hormone Replacement Therapy: Diskussionen zur Postmenopausalen ... Foundation Symposium Proceedings, 13)

Menopause: Endocrinology and Management: 18 (Contemporary Endocrinology, 18)

The Menopause (Clinical Perspectives in Obstetrics and Gynecology)

Hormonal Carcinogenesis: Proceedings of the First International Symposium

The Management of the Menopause & Post-Menopausal Years: The Proceedings of the International Symposium held in London 24–26 November 1975 Arranged by ... and Gynaecology, The University of London

Essentials of Menopause Management: A Case-Based Approach

New Molecular Mechanisms of Estrogen Action and Their Impact on Future Perspectives in Estrogen Therapy: 46 (Ernst Schering Foundation Symposium Proceedings, 46)

Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs

Estrogen ― Mystery Drug for the Brain?: The Neuroprotective Activities of the Female Sex Hormone

Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)

Hormonal Pathology of the Uterus: 1242 (Advances in Experimental Medicine and Biology, 1242)

RED: Women's Health From Menarche to Menopause

Biology of Menopause (Serono Symposia USA)

Hormones and Cancer: 138 (Advances in Experimental Medicine and Biology, 138)

THE MENOPAUSE & PERIMENOPAUSE CLINICAL PROTOCOLS DESK REFERENCE FOR NURSE PRACTITIONERS: MHT/HRT prescribing algorithms, dosing tables, contraindication screening, GSM and vasomotor symptom management

Approaches to Breast Cancer Prevention: 62 (Developments in Oncology, 62)

Coronary Disease in Women: Evidence-Based Diagnosis and Treatment (Contemporary Cardiology)

Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)

Endocrine Therapies in Breast and Prostate Cancer: 39 (Cancer Treatment and Research, 39)

Perimenopause (Serono Symposia USA)

Progestogens in Obstetrics and Gynecology

Endocrine Therapies in Breast and Prostate Cancer: 39 (Cancer Treatment and Research, 39)

Estrogen's role in cardiovascular health: The role of estrogen in the maintenance of healthy endothelium under conditions of oxidative stress, apoptosis and angiogenesis